Amexdrug Corp. (AXRX) Financial Statements (2024 and earlier)

Company Profile

Business Address 369 SOUTH DOHENY DR SUITE 326
BEVERLY HILLS, CA 90211
State of Incorp. CA
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments
Cash and cash equivalents
Short-term investments
Receivables
Inventory, net of allowances, customer advances and progress billings
Inventory
Prepaid expense and other current assets
Other undisclosed current assets
Total current assets:
Noncurrent Assets
Property, plant and equipment
Intangible assets, net (including goodwill)
Goodwill
Deposits noncurrent assets
Other undisclosed noncurrent assets
Total noncurrent assets:
Other undisclosed assets
TOTAL ASSETS:
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities
Accounts payable
Accrued liabilities
Debt
Other undisclosed current liabilities
Total current liabilities:
Noncurrent Liabilities
Long-term debt and lease obligation
Long-term debt, excluding current maturities
Total noncurrent liabilities:
Total liabilities:
Equity
Equity, attributable to parent
Common stock
Treasury stock, value
Additional paid in capital
Retained earnings
Total equity:
TOTAL LIABILITIES AND EQUITY:

Income Statement (P&L) ($ in thousands)

12/31/2012
Revenues
Cost of revenue
Cost of goods and services sold
Other undisclosed gross profit
Gross profit:
Operating expenses
Other undisclosed operating loss
Operating income:
Nonoperating expense
Other nonoperating expense
Interest and debt expense
Income from continuing operations before equity method investments, income taxes:
Other undisclosed loss from continuing operations before income taxes
Income from continuing operations before income taxes:
Income tax expense
Income from continuing operations:
Income before gain (loss) on sale of properties:
Net income available to common stockholders, diluted:

Comprehensive Income ($ in thousands)

12/31/2012
Net income:
Comprehensive income, net of tax, attributable to parent:

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: